Association between statin use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database.

Front Immunol · 2024 · PMC11493589 · PMID 39439792

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Association of statin use with irAEs in CTLA-4 inhibitor therapy In the cohort treated with CTLA-4 inhibitors, an analysis revealed a nonsignificant trend toward an enhanced risk of irAEs among patients using statins compared to their non-statin-using counterparts.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.